BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22864788)

  • 1. Global gene expression differentiating pure bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar carcinoma features.
    Zhang WC; Zhang ZF; You J; Wang CL
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):765-71. PubMed ID: 22864788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
    Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
    J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B
    Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung adenocarcinoma global profiling identifies type II transforming growth factor-beta receptor as a repressor of invasiveness.
    Borczuk AC; Kim HK; Yegen HA; Friedman RA; Powell CA
    Am J Respir Crit Care Med; 2005 Sep; 172(6):729-37. PubMed ID: 15976377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
    Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
    Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features.
    Aviel-Ronen S; Coe BP; Lau SK; da Cunha Santos G; Zhu CQ; Strumpf D; Jurisica I; Lam WL; Tsao MS
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10155-60. PubMed ID: 18632575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.
    Haneda H; Sasaki H; Lindeman N; Kawano O; Endo K; Suzuki E; Shimizu S; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Feb; 36(2):69-75. PubMed ID: 16449241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.
    Seki Y; Yoshida Y; Ishimine H; Shinozaki-Ushiku A; Ito Y; Sumitomo K; Nakajima J; Fukayama M; Michiue T; Asashima M; Kurisaki A
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1141-7. PubMed ID: 24380866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
    Miller VA; Riely GJ; Zakowski MF; Li AR; Patel JD; Heelan RT; Kris MG; Sandler AB; Carbone DP; Tsao A; Herbst RS; Heller G; Ladanyi M; Pao W; Johnson DH
    J Clin Oncol; 2008 Mar; 26(9):1472-8. PubMed ID: 18349398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression patterns of paired bronchioloalveolar carcinoma and benign lung tissue.
    Goodwin LO; Mason JM; Hajdu SI
    Ann Clin Lab Sci; 2001 Oct; 31(4):369-75. PubMed ID: 11688848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of bronchioloalveolar carcinoma with new histologic and staging definitions.
    Ebbert JO; Chhatwani L; Aubry MC; Wampfler J; Stoddard S; Zhang F; Qiao G; de Andrade M; Yang P
    J Thorac Oncol; 2010 Aug; 5(8):1213-20. PubMed ID: 20592627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition?
    Ohori NP; Santa Maria EL
    Am J Clin Pathol; 2004 Jul; 122(1):44-50. PubMed ID: 15272529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchioloalveolar differentiation in lung adenocarcinomas.
    Dukić N; Babić B; Eri Z; Zec D; Lovrenski A; Kolarov V
    Bosn J Basic Med Sci; 2011 Nov; 11(4):248-52. PubMed ID: 22117833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.
    Mackinnon AC; Tretiakova M; Henderson L; Mehta RG; Yan BC; Joseph L; Krausz T; Husain AN; Reid ME; Salgia R
    J Clin Pathol; 2011 Jan; 64(1):16-24. PubMed ID: 21045234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
    Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
    Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
    Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
    Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
    Karoubi G; Gugger M; Schmid R; Dutly A
    Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization.
    Terasaki H; Niki T; Matsuno Y; Yamada T; Maeshima A; Asamura H; Hayabuchi N; Hirohashi S
    Am J Surg Pathol; 2003 Jul; 27(7):937-51. PubMed ID: 12826886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.